Achieve Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $34.9M | $34.9M | $15.0K | $380.0K |
| FY2010 | $-26.8M | $-26.9M | $68.0K | $642.0K |
| FY2011 | $-20.3M | $-20.3M | $79.0K | $1.2M |
| FY2012 | $-43.5M | $-43.8M | $291.0K | $2.2M |
| FY2013 | $-35.9M | $-36.2M | $253.0K | $2.8M |
| FY2014 | $-17.3M | $-17.4M | $82.0K | $3.9M |
| FY2015 | $-350.0K | $-721.0K | $371.0K | $2.3M |
| FY2016 | $-202.0K | $-248.0K | $46.0K | $1.6M |
| FY2017 | $-9.1M | $-9.1M | — | $348.0K |
| FY2018 | $-10.6M | $-10.7M | $46.0K | $854.0K |
| FY2019 | $-15.2M | $-15.3M | $53.0K | $1.2M |
| FY2020 | $-13.5M | $-13.5M | $17.0K | $1.3M |
| FY2021 | $-29.4M | $-29.4M | — | $2.2M |
| FY2022 | $-37.6M | $-37.6M | — | $3.3M |
| FY2023 | $-24.5M | $-24.5M | $21.0K | $3.4M |
| FY2024 | $-29.8M | $-29.8M | — | $5.3M |
| FY2025 | $-49.5M | $-49.5M | $3.0K | $8.8M |